ロシュ・ホールディングは、乳がん薬ギレデストラントの第3相persevERA試験が主要評価項目を達成できなかったことを受け、株価が大幅に下落した。この挫折にもかかわらず、同社は同薬の他の適応症での可能性に楽観的であり続けている。アナリストらは、この結果をロシュの広範なポートフォリオにとって存在を脅かすものではない障害と見なしている。
ロシュ・ホールディング（ティッカーRHHBYおよびRHHBF）は、2026年3月11日、第3相persevERA試験の失望的な結果を発表した後、株価が顕著に下落した。この試験は実験的な乳がん治療薬ギレデストラントを検証したが、主要評価項目を達成しなかった。
Shiseido's shares rose the most in nearly eight years after its fourth-quarter earnings and full-year forecast beat analyst estimates. The stock surged as much as 15% in Tokyo trading on Thursday, marking the biggest intraday gain since May 2018. The cosmetics giant is cutting costs and prioritizing core brands amid its toughest business conditions in decades.
AIによるレポート
Kering CEO Luca de Meo presented his 'ReconKering' strategy at the company's Capital Markets Day in Florence on Thursday, aiming to reposition the luxury group as a top challenger. The plan targets doubling the recurring operating margin to around 2030 and outperforming market sales growth. De Meo, who joined from Renault last year, highlighted recent challenges including flat first-quarter sales and Gucci's decline.
The Neuberger Real Estate Securities Income Fund (NRO) is trading at an -8.18% discount to its net asset value, making it a more attractive option compared to previous assessments. This closed-end fund offers a 12.36% distribution yield, though it faces risks from ongoing net asset value declines and potential overdistribution. Its portfolio focuses on value-oriented investments in healthcare and office real estate investment trusts.
AIによるレポート
Shares of Torrid Holdings (NYSE:CURV) jumped 28% on March 20 following better-than-expected Q4 fiscal 2025 results. Despite ongoing declines in revenue and profitability, the company outlined turnaround efforts including store optimization and sub-brand expansion. Management forecasts improved EBITDA and cash flow for 2026.